An AllTrials project

NCT03451292: An ongoing trial by Grifols Therapeutics LLC

This trial is ongoing. It must report results 1 year, 2 months from now.

Full data

Full entry on ClinicalTrials.gov NCT03451292
Title Prevention of Mortality With Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date July 24, 2018
Completion date May 31, 2024
Required reporting date May 31, 2025, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None